EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSCSEG00000018918
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSCSEG00000005766
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSCSEG00000012994
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSCSEG00000000249
Gene Symbol: SELE
4 Cross references
181 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSCSEG00000016061
Gene Symbol: LOC103397571
3 Cross references
190 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSCSEG00000012037
Gene Symbol: LOC103397124
3 Cross references
190 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSCSEG00000007742
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSCSEG00000001929
Gene Symbol: LOC103388165
2 Cross references
352 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSCSEG00000009783
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSCSEG00000020064
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSCSEG00000017334
Gene Symbol: SIRT1
3 Cross references
158 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSCSEG00000009177
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).